Board of Directors
Gordon Baty, Ph.D.
Chairman of the Board
Gordon Baty has over 40 years of experience with early-stage ventures and finance. He has started, managed, merged, sold, financed, studied, advised and on occasion buried, numerous entrepreneurial ventures. He has built a succession of high tech firms and has taught entrepreneurship and venture finance at MIT Sloan School and Northeastern University. He was a founder and managing director at Zero Stage Capital, a venture capital firm specializing in early-stage technology ventures. He also started and served as Chairman of Navigator Technology Ventures, a technology commercialization fund. He currently serves as Chairman at Passport Systems, a company developing technology for the detection of molecular signatures in cargo materials, and served for many years as a board member at Charles Stark Draper Laboratory at MIT. He holds BS, MS and PhD (finance) degrees from MIT.
Deborah DiSanzo has over 25 years experience in leading healthcare technology companies. She is currently the Head of IBM’s Watson Health. Before this, Ms. DiSanzo was the Chief Executive Officer of Philips Healthcare, a $10 billion euro healthcare technology company providing solutions in healthcare informatics, patient monitoring and patient analytics, home healthcare, imaging systems, and healthcare consulting. Prior to this, she held numerous leadership positions within Philips Healthcare, Agilent Technologies, and Hewlett-Packard. She was the Chief Executive Officer of Philips Healthcare’s Patient Care and Clinical Informatics business group. She also served as Senior Vice President and General Manager of Philips Patient Monitoring business, and held a variety of management positions in Cardiac Care, where she was instrumental in building the Automated External Defibrillator market. She earned a Master’s of Business Administration from Babson College, and a Bachelor of Science from Merrimack College. Ms. DiSanzo was inducted into the Babson Alumni Entrepreneur Hall of Fame, and received Babson’s Founder’s Day Award for Entrepreneurship.
Nader Yaghoubi, M.D., Ph.D.
President and Chief Executive Officer
Dr. Yaghoubi has over 20 years of experience in the creation, operations and financing of life science companies. Before his involvement with PathMaker Neurosystems, he established, as President and Founding CEO, Symbiotix Biotherapies, a pioneering microbiome company developing novel molecular therapeutics based on the human microbiome. Prior to Symbiotix, he was the first employee at Selecta Biosciences and BIND Therapeutics (Nasdaq:BIND), where he worked with the founders to launch the companies and establish operations and corporate development. Previously, he was at Zero Stage Capital, a venture capital firm where he was responsible for investing in the life sciences sector, and earlier completed an internship at Advent International. Prior to this, he was a Health Care Entrepreneurship Fellow at Boston University, where he worked with scientists and physicians to develop new businesses in the healthcare and life science sector. Before his fellowship, he was a surgical resident in the Department of Surgery at Lenox Hill Hospital in New York. Dr. Yaghoubi received an M.D. and Ph.D. in Molecular Pharmacology from the combined degree program at Boston University School of Medicine. His doctorate work on the development of high-throughput automated electrophysiological systems resulted in five issued patents, received one of the University’s highest awards for dissertational research, and was the basis of a venture-backed biotechnology company focused on neuroscience. He is extensively involved in mentoring young companies, and has served/serves as a mentor, advisor and reviewer with MBC’s MassCONNECT program, Mass Life Sciences Center programs, Springboard Venture Capital Forum and numerous university business plan competitions.
Jake Maslow, J.D.
Jake Maslow has 30 years of experience in various aspects of entrepreneurialism and IP commercialization, including recognition of innovation and commercial opportunity in new technologies, assisting startups and business formation, managing team formation and strategic growth, fund raising, strategic partnering, high-tech new product development and marketing, university licensing, and corporate and IP law. He was a former Director of the CUNY Technology Commercialization Office and was former Assistant Director of MIT Patents and Technology Licensing Office. Jake has been co-founder of several startups based on technologies out of MIT. As co-founder and CEO of Synkinetics, Inc., Jake successfully built a high-tech engineering company based on a proprietary high precision drive system for industrial and military applications, securing sponsorship of several leading F-500 companies, and supported by 30 angel investors, while generating substantial federal and commercial grants and revenues. As Co-founder and IP counsel / Strategic Advisor of Sionex Corporation, Jake introduced successful VC investment to support development of state-of-the-art lab-on-a-chip for real-time chemical detection; while working closely with C-level engineering and marketing to build substantial IP portfolio and to secure market entry; He is a graduate of Columbia University (CC’73, PS) and Brooklyn Law School (Juris Doctorate ‘76), and is a member of the New York and Massachusetts Bar and a registered US patent attorney. Jake also is an Air Force veteran, having graduated USAF Radar Electronics School (1968) and served as radar technician for the F4 Phantom Jet.